Correlation Between Kodiak Sciences and Neximmune
Can any of the company-specific risk be diversified away by investing in both Kodiak Sciences and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kodiak Sciences and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kodiak Sciences and Neximmune, you can compare the effects of market volatilities on Kodiak Sciences and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kodiak Sciences with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kodiak Sciences and Neximmune.
Diversification Opportunities for Kodiak Sciences and Neximmune
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Kodiak and Neximmune is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Kodiak Sciences and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Kodiak Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kodiak Sciences are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Kodiak Sciences i.e., Kodiak Sciences and Neximmune go up and down completely randomly.
Pair Corralation between Kodiak Sciences and Neximmune
If you would invest 354.00 in Kodiak Sciences on August 24, 2024 and sell it today you would earn a total of 236.00 from holding Kodiak Sciences or generate 66.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
Kodiak Sciences vs. Neximmune
Performance |
| Timeline |
| Kodiak Sciences |
| Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kodiak Sciences and Neximmune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kodiak Sciences and Neximmune
The main advantage of trading using opposite Kodiak Sciences and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kodiak Sciences position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.| Kodiak Sciences vs. Reviva Pharmaceuticals Holdings | Kodiak Sciences vs. Eyenovia | Kodiak Sciences vs. Cognition Therapeutics | Kodiak Sciences vs. Transcode Therapeutics |
| Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |